Yuxiang Chen

721 total citations
26 papers, 367 citations indexed

About

Yuxiang Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yuxiang Chen has authored 26 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Yuxiang Chen's work include Circular RNAs in diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer therapeutics and mechanisms (2 papers). Yuxiang Chen is often cited by papers focused on Circular RNAs in diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer therapeutics and mechanisms (2 papers). Yuxiang Chen collaborates with scholars based in China, United States and United Kingdom. Yuxiang Chen's co-authors include Zhang Yang-de, Jingfeng Zhao, Jian Li, Jinbang Li, Longmei Cai, Xiaoming Lyu, Xin Li, Yongjin Bao, Junsheng Yang and Weibo Chen and has published in prestigious journals such as PLoS ONE, Oncotarget and Bioorganic & Medicinal Chemistry.

In The Last Decade

Yuxiang Chen

22 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxiang Chen China 10 166 154 132 58 54 26 367
Xiaoju Shi China 13 126 0.8× 128 0.8× 69 0.5× 57 1.0× 77 1.4× 35 415
Huajie Zong China 6 219 1.3× 114 0.7× 160 1.2× 29 0.5× 42 0.8× 10 317
Malee Warnnissorn Thailand 10 135 0.8× 109 0.7× 130 1.0× 52 0.9× 54 1.0× 32 371
Jadzia Tin-Tsen Chou Poland 6 157 0.9× 150 1.0× 74 0.6× 97 1.7× 60 1.1× 15 421
Chaoxi Zhou China 10 188 1.1× 80 0.5× 122 0.9× 31 0.5× 39 0.7× 32 318
Tianliang Xia China 12 241 1.5× 119 0.8× 125 0.9× 44 0.8× 22 0.4× 21 366
Houyu Ju China 14 214 1.3× 162 1.1× 146 1.1× 69 1.2× 30 0.6× 28 415
Xueke Qian China 8 276 1.7× 132 0.9× 258 2.0× 79 1.4× 20 0.4× 14 502
Shaocong Wu China 10 255 1.5× 199 1.3× 130 1.0× 96 1.7× 23 0.4× 14 454
Hongze Chen China 14 319 1.9× 209 1.4× 214 1.6× 83 1.4× 131 2.4× 21 594

Countries citing papers authored by Yuxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Yuxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Chen more than expected).

Fields of papers citing papers by Yuxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Chen. The network helps show where Yuxiang Chen may publish in the future.

Co-authorship network of co-authors of Yuxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Chen. A scholar is included among the top collaborators of Yuxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Chen. Yuxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuxiang, et al.. (2024). Impact of Physical Activity Frequency, Duration, and Intensity on Senile Cataract Risk: A Mendelian Randomization Study. Translational Vision Science & Technology. 13(5). 26–26.
2.
Zheng, Zhaohui, Changxing Li, Qi Wang, et al.. (2024). Emodin combined with 5‐aminolevulinic acid photodynamic therapy inhibits condyloma acuminate angiogenesis by targeting SerRS. Journal of Cellular and Molecular Medicine. 28(19). e70122–e70122.
3.
4.
Chen, Qin, Yuxiang Chen, Ruijin Hong, et al.. (2024). A Visualized Nomogram for Predicting Prognosis in Elderly Patients after Percutaneous Coronary Intervention. Reviews in Cardiovascular Medicine. 25(5). 155–155.
5.
Lv, Ya, Deming Chen, Xinyi Tian, et al.. (2023). Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis. Journal of Translational Medicine. 21(1). 293–293. 30 indexed citations
6.
Chen, Yuxiang, et al.. (2023). Evaluation of a novel lyophilized-pellet-based 2019-nCoV nucleic acid detection kit for the diagnosis of COVID-19. PLoS ONE. 18(10). e0292902–e0292902. 1 indexed citations
7.
Chen, Yuxiang, Lihua Chen, Ruijin Hong, et al.. (2023). Effects of percutaneous coronary intervention and diabetes mellitus on short- and long-term prognosis assessed by the three-vessel quantitative flow ratio. Diabetes Research and Clinical Practice. 206. 111013–111013. 2 indexed citations
8.
9.
Zhu, Li, Yuxiang Chen, Wei Ding, et al.. (2022). Caspase-3/Treg and PI3K/AKT/mTOR pathway is involved in Liver Ischemia Reperfusion Injury (IRI) protection by everolimus. Transplant Immunology. 71. 101541–101541. 3 indexed citations
10.
Chen, Yuxiang, et al.. (2021). Design, synthesis and anti-fibrosis evaluation of imidazo[1,2–a]pyridine derivatives as potent ATX inhibitors. Bioorganic & Medicinal Chemistry. 46. 116362–116362. 3 indexed citations
11.
Li, Tong, et al.. (2021). Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLLrearranged Leukemia. Mini-Reviews in Medicinal Chemistry. 21(11). 1337–1350. 5 indexed citations
12.
Chen, Yuxiang, Chi Liu, Shaomi Zhu, et al.. (2021). PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer. International Immunopharmacology. 96. 107607–107607. 18 indexed citations
13.
Li, Wei, Tianming Zhao, Yuxiang Chen, et al.. (2020). Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants. Bioorganic & Medicinal Chemistry. 28(20). 115719–115719. 10 indexed citations
14.
Chen, Yuxiang, et al.. (2020). Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations. Bioorganic & Medicinal Chemistry. 28(20). 115715–115715. 8 indexed citations
15.
Chen, Yuxiang, et al.. (2019). Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems. Journal of Visualized Experiments. 2 indexed citations
16.
Cai, Longmei, Jinbang Li, Xiaona Zhang, et al.. (2015). Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma. Oncotarget. 6(10). 7838–7850. 54 indexed citations
17.
Li, Jian, et al.. (2011). Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Molecular and Cellular Biochemistry. 357(1-2). 31–38. 83 indexed citations
18.
Yu, Shuyi, et al.. (2008). A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo. Cancer Biology & Therapy. 7(7). 1037–1043. 33 indexed citations
19.
Cochran, David J., et al.. (2007). Perceived and Actual Grasp Forces on Cylindrical Handles. Human Factors The Journal of the Human Factors and Ergonomics Society. 49(2). 292–299. 8 indexed citations
20.
Yang, Yongjia, Jihong Guo, Zheng Liu, et al.. (2006). A locus for autosomal dominant accessory auricular anomaly maps to 14q11.2–q12. Human Genetics. 120(1). 144–147. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoju Shi Breakdown of academic impact, for papers by Huajie Zong Breakdown of academic impact, for papers by Malee Warnnissorn Breakdown of academic impact, for papers by Jadzia Tin-Tsen Chou Breakdown of academic impact, for papers by Chaoxi Zhou Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Houyu Ju Breakdown of academic impact, for papers by Xueke Qian Breakdown of academic impact, for papers by Shaocong Wu Breakdown of academic impact, for papers by Hongze Chen
Rankless by CCL
2026